Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea
· Delayed Price · Currency is KRW 5,290.00
+30.00 (0.57%)
At close: Dec 5, 2025
Sinsin Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Cash & Equivalents | 1,739 | 539.85 | 346.46 | 2,240 | 799.33 | 2,504 | Upgrade
|
| Cash & Short-Term Investments | 1,739 | 539.85 | 346.46 | 2,240 | 799.33 | 2,504 | Upgrade
|
| Cash Growth | -43.37% | 55.82% | -84.53% | 180.24% | -68.08% | 77.61% | Upgrade
|
| Accounts Receivable | 33,884 | 30,605 | 27,975 | 25,771 | 23,237 | 22,526 | Upgrade
|
| Other Receivables | 2,789 | 2,229 | 2,216 | 1,953 | 1,652 | 1,479 | Upgrade
|
| Receivables | 36,672 | 32,833 | 30,191 | 27,724 | 24,889 | 24,005 | Upgrade
|
| Inventory | 19,144 | 16,643 | 15,733 | 14,390 | 10,370 | 12,371 | Upgrade
|
| Prepaid Expenses | 335.02 | 103.01 | 160.45 | 34.91 | 33.79 | 70.89 | Upgrade
|
| Other Current Assets | 1,116 | 1,374 | 676.95 | 659.08 | 375.07 | 729.2 | Upgrade
|
| Total Current Assets | 59,007 | 51,492 | 47,108 | 45,048 | 36,467 | 39,680 | Upgrade
|
| Property, Plant & Equipment | 64,297 | 65,718 | 68,264 | 66,825 | 69,345 | 70,034 | Upgrade
|
| Long-Term Investments | 7,486 | 6,649 | 3,270 | 3,559 | 3,183 | 3,180 | Upgrade
|
| Other Intangible Assets | 567.67 | 580.53 | 586.32 | 592.29 | 499.07 | 499.07 | Upgrade
|
| Long-Term Accounts Receivable | - | -0 | -0 | -0 | -0 | 1.84 | Upgrade
|
| Long-Term Deferred Tax Assets | 1,700 | 1,666 | 1,612 | 1,400 | 1,394 | 1,184 | Upgrade
|
| Other Long-Term Assets | 3,049 | 3,379 | 3,570 | 3,790 | 3,418 | 3,555 | Upgrade
|
| Total Assets | 136,106 | 129,484 | 124,409 | 121,213 | 114,307 | 118,134 | Upgrade
|
| Accounts Payable | 6,627 | 7,256 | 7,060 | 6,815 | 4,746 | 6,911 | Upgrade
|
| Accrued Expenses | 1,465 | 902.13 | 845.07 | 864.38 | 784.18 | 647.39 | Upgrade
|
| Short-Term Debt | 20,861 | 20,706 | 16,142 | 11,794 | 12,720 | 9,916 | Upgrade
|
| Current Portion of Long-Term Debt | 21,930 | 20,793 | 18,384 | 12,629 | 8,590 | 8,205 | Upgrade
|
| Current Portion of Leases | 137.13 | 170.47 | 76.79 | 132.21 | 116.44 | 71.6 | Upgrade
|
| Current Income Taxes Payable | 505.87 | 273.84 | 169.82 | 186.45 | - | 1,678 | Upgrade
|
| Other Current Liabilities | 10,765 | 8,999 | 9,042 | 9,907 | 6,962 | 6,954 | Upgrade
|
| Total Current Liabilities | 62,290 | 59,101 | 51,720 | 42,327 | 33,919 | 34,382 | Upgrade
|
| Long-Term Debt | 1,578 | 3,822 | 9,843 | 18,865 | 24,676 | 26,857 | Upgrade
|
| Long-Term Leases | 47.08 | 115.36 | 59.01 | 61.44 | 133.54 | 127.43 | Upgrade
|
| Pension & Post-Retirement Benefits | 204.51 | - | - | 115.17 | 198.36 | 509.41 | Upgrade
|
| Other Long-Term Liabilities | 978.71 | 877.82 | 696.83 | 313.31 | 580.1 | 210 | Upgrade
|
| Total Liabilities | 65,099 | 63,915 | 62,319 | 61,682 | 59,507 | 62,086 | Upgrade
|
| Common Stock | 7,585 | 7,585 | 7,585 | 7,585 | 7,585 | 7,585 | Upgrade
|
| Additional Paid-In Capital | 14,450 | 14,450 | 14,450 | 14,450 | 14,450 | 14,450 | Upgrade
|
| Retained Earnings | 49,712 | 44,875 | 41,019 | 37,478 | 32,890 | 34,150 | Upgrade
|
| Comprehensive Income & Other | -438.98 | -1,037 | -759.18 | 184.15 | 1.31 | 9.58 | Upgrade
|
| Total Common Equity | 71,309 | 65,874 | 62,295 | 59,698 | 54,927 | 56,195 | Upgrade
|
| Minority Interest | -301.11 | -304.86 | -204.62 | -166.81 | -126.43 | -147.38 | Upgrade
|
| Shareholders' Equity | 71,008 | 65,569 | 62,090 | 59,531 | 54,800 | 56,048 | Upgrade
|
| Total Liabilities & Equity | 136,106 | 129,484 | 124,409 | 121,213 | 114,307 | 118,134 | Upgrade
|
| Total Debt | 44,553 | 45,606 | 44,505 | 43,481 | 46,236 | 45,177 | Upgrade
|
| Net Cash (Debt) | -42,813 | -45,066 | -44,158 | -41,241 | -45,437 | -42,673 | Upgrade
|
| Net Cash Per Share | -2819.94 | -2970.66 | -2910.81 | -2718.51 | -2995.06 | -2812.89 | Upgrade
|
| Filing Date Shares Outstanding | 15.14 | 15.17 | 15.17 | 15.17 | 15.17 | 15.17 | Upgrade
|
| Total Common Shares Outstanding | 15.14 | 15.17 | 15.17 | 15.17 | 15.17 | 15.17 | Upgrade
|
| Working Capital | -3,283 | -7,608 | -4,612 | 2,720 | 2,548 | 5,297 | Upgrade
|
| Book Value Per Share | 4709.92 | 4342.22 | 4106.33 | 3935.14 | 3620.62 | 3704.24 | Upgrade
|
| Tangible Book Value | 70,741 | 65,293 | 61,709 | 59,106 | 54,428 | 55,696 | Upgrade
|
| Tangible Book Value Per Share | 4672.42 | 4303.95 | 4067.68 | 3896.09 | 3587.73 | 3671.34 | Upgrade
|
| Land | 13,944 | 13,944 | 13,944 | 13,860 | 13,722 | 13,722 | Upgrade
|
| Buildings | 44,624 | 44,477 | 44,264 | 44,093 | 43,922 | 43,138 | Upgrade
|
| Machinery | 34,179 | 33,875 | 32,628 | 27,545 | 26,864 | 25,014 | Upgrade
|
| Construction In Progress | 344.68 | - | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.